<p>Fortrea Holdings（納斯達克股票代碼：FTRE）在過去三個月內被 6 位分析師進行了分析，顯示出從看漲到看跌的多樣化觀點。</p>
<p>下表提供了分析師最近評級的簡明概述，展示了過去 30 天情緒的變化，並與前幾個月進行了比較，以提供全面的視角。</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>分析師為 Fortrea Holdings 設定了 12 個月的價格目標，顯示出平均目標為 15.5 美元，最高預估為 25.00 美元，最低預估為 9.00 美元。這一上升趨勢顯而易見，目前的平均值反映出比之前的平均價格目標 10.33 美元增加了 50.05%。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="價格目標圖表" original-src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png"/></p>
<h2>解讀分析師評級：深入分析</h2>
<p>對最近分析師行動的深入分析揭示了金融專家對 Fortrea Holdings 的看法。以下總結概述了關鍵分析師、他們最近的評估以及對評級和價格目標的調整。</p>
<table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上調</td>
<td>超越大盤</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中性</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>持平</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>低於大盤</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中性</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<h3>關鍵洞察：</h3>
<ul>
<li><strong>採取的行動：</strong> 針對市場動態和公司表現的變化，分析師更新他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，都表明他們對 Fortrea Holdings 近期發展的反應。這為分析師對公司當前狀態的看法提供了洞察。</li>
<li><strong>評級：</strong> 分析師揭示了對股票的定性評估，從 ‘超越大盤’ 到 ‘低於大盤’。這些評級提供了對 Fortrea Holdings 相對於更廣泛市場表現的預期洞察。</li>
<li><strong>價格目標：</strong> 分析師提供了價格目標的洞察，給出對 Fortrea Holdings 股票未來價值的估計。這一比較揭示了分析師預期隨時間變化的趨勢。</li>
</ul>
<p>為了獲取有關 Fortrea Holdings 市場表現的有價值洞察，請考慮將這些分析師評估與關鍵財務指標結合起來。保持信息靈通，利用我們的評級表做出明智的決策。</p>
<p>隨時瞭解 Fortrea Holdings 的分析師評級。</p>
<p>如果您對跟蹤小型股新聞和表現感興趣，您可以從這裏開始跟蹤。</p>
<h2>關於 Fortrea Holdings</h2>
<p>Fortrea 是一家全球性的晚期合同研究組織，提供從第一階段到第四階段的臨牀試驗管理、臨牀藥理學和患者接入解決方案。該公司與新興和大型生物製藥、醫療設備和診斷公司合作，作為功能服務提供商、全方位服務提供商進行臨牀試驗，並提供混合試驗。2023 年，Fortrea 作為一家獨立的上市公司成立，此前 Labcorp 將其臨牀開發業務剝離，該業務是通過 2015 年以 61 億美元收購 Covance 而獲得的。Fortrea 在 90 個國家擁有 19,000 名員工。</p>
<h3>Fortrea Holdings：深入財務分析</h3>
<p><strong>市值視角：</strong> 該公司的市值低於行業平均水平，表明其相較於同行規模相對較小。這一定位可能受到感知增長潛力或運營規模等因素的影響。</p>
<p><strong>收入增長：</strong> Fortrea Holdings 在過去 3 個月的收入增長顯著。截至 2025 年 9 月 30 日，該公司的收入增長率約為 <strong>3.91%</strong>。這表明公司的頂線收益有了顯著增加。與競爭對手相比，該公司面臨困難，增長率低於醫療保健行業同行的平均水平。</p>
<p><strong>淨利潤率：</strong> Fortrea Holdings 的淨利潤率低於行業平均水平，表明在保持強勁盈利能力方面可能面臨挑戰。淨利潤率為 <strong>-2.27%</strong>，公司在有效成本管理方面可能面臨困難。</p>
<p><strong>股本回報率（ROE）：</strong> Fortrea Holdings 的 ROE 低於行業標準，表明在有效利用股本方面存在困難。ROE 為 <strong>-2.72%</strong>，公司可能面臨為股東提供滿意回報的挑戰。</p>
<p><strong>資產回報率（ROA）：</strong> Fortrea Holdings 的 ROA 低於行業平均水平，表明在有效利用資產方面存在挑戰。ROA 為 <strong>-0.57%</strong>，公司可能面臨從其資產中產生最佳回報的困難。</p>
<p><strong>債務管理：</strong> Fortrea Holdings 的債務與股本比率超過行業規範，達到 <strong>2.04</strong>。這表明公司承擔了大量債務，可能面臨財務挑戰。</p>
<h2>什麼是分析師評級？</h2>
<p>評級來自分析師或銀行和金融系統內的專家，他們針對特定股票或定義的行業進行報告（通常每季度對每隻股票進行一次）。分析師通常從公司電話會議和會議、財務報表以及與重要內部人士的對話中獲取信息，以做出決策。</p>
<p>除了標準評估外，一些分析師還會對增長預估、收益和收入等指標提供預測，為投資者提供額外的指導。使用分析師評級的用户應注意，這些專業建議受到人類觀點的影響，可能會存在變動。</p>
<p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>

FTRE

<p>Fortrea Holdings（納斯達克代碼：FTRE）在過去三個月內獲得了 6 位分析師的混合評級，12 個月的平均目標價為 15.5 美元，較之前的目標價反映出 50.05% 的增長。分析師們提高了他們的評級，其中 Evercore ISI 和花旗集團等公司的增幅尤為顯著。儘管收入增長了 3.91%，但 Fortrea 的財務指標，包括淨利潤率（-2.27%）和股本回報率（-2.72%），均低於行業平均水平，顯示出潛在的挑戰。該公司由 Labcorp 的分拆而成，作為一家全球合同研究組織，在 90 個國家擁有 19,000 名員工</p>

<p>Fortrea Holdings (NASDAQ: FTRE) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<div class="lb-trans"><p>Fortrea Holdings（納斯達克股票代碼：FTRE）在過去三個月內被 6 位分析師進行了分析，顯示出從看漲到看跌的多樣化觀點。</p>
</div><p>The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.</p>
<div class="lb-trans"><p>下表提供了分析師最近評級的簡明概述，展示了過去 30 天情緒的變化，並與前幾個月進行了比較，以提供全面的視角。</p>
</div><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th align="right"><strong>看漲</strong></th>
<th align="right"><strong>稍微看漲</strong></th>
<th align="right"><strong>無所謂</strong></th>
<th align="right"><strong>稍微看跌</strong></th>
<th align="right"><strong>看跌</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>總評級</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>過去 30 天</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1 個月前</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3 個月前</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
</div><p>Analysts have set 12-month price targets for Fortrea Holdings, revealing an average target of $15.5, a high estimate of $25.00, and a low estimate of $9.00. This upward trend is evident, with the current average reflecting a 50.05% increase from the previous average price target of $10.33.</p>
<div class="lb-trans"><p>分析師為 Fortrea Holdings 設定了 12 個月的價格目標，顯示出平均目標為 15.5 美元，最高預估為 25.00 美元，最低預估為 9.00 美元。這一上升趨勢顯而易見，目前的平均值反映出比之前的平均價格目標 10.33 美元增加了 50.05%。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.benzinga.com/files/images/story/2026/1767736909_0.png" alt="price target chart" original-src="https://www.benzinga.com/files/images/story/2026/1767736909_0.png"/></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<div class="lb-trans"><h2>解讀分析師評級：深入分析</h2>
</div><p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Fortrea Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<div class="lb-trans"><p>對最近分析師行動的深入分析揭示了金融專家對 Fortrea Holdings 的看法。以下總結概述了關鍵分析師、他們最近的評估以及對評級和價格目標的調整。</p>
</div><table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Underweight</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Neutral</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th>分析師</th>
<th>分析師公司</th>
<th>採取的行動</th>
<th>評級</th>
<th>當前價格目標</th>
<th>之前價格目標</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elizabeth Anderson</td>
<td>Evercore ISI Group</td>
<td>上調</td>
<td>超越大盤</td>
<td>$25.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中性</td>
<td>$13.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>持平</td>
<td>$15.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Patrick Donnelly</td>
<td>Citigroup</td>
<td>上調</td>
<td>買入</td>
<td>$21.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>上調</td>
<td>低於大盤</td>
<td>$10.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>上調</td>
<td>中性</td>
<td>$9.00</td>
<td>$7.00</td>
</tr>
</tbody>
</table>
</div><h3>Key Insights:</h3>
<div class="lb-trans"><h3>關鍵洞察：</h3>
</div><ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Fortrea Holdings. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Fortrea Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Fortrea Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>採取的行動：</strong> 針對市場動態和公司表現的變化，分析師更新他們的建議。無論是 ‘維持’、‘上調’ 還是 ‘下調’ 他們的立場，都表明他們對 Fortrea Holdings 近期發展的反應。這為分析師對公司當前狀態的看法提供了洞察。</li>
<li><strong>評級：</strong> 分析師揭示了對股票的定性評估，從 ‘超越大盤’ 到 ‘低於大盤’。這些評級提供了對 Fortrea Holdings 相對於更廣泛市場表現的預期洞察。</li>
<li><strong>價格目標：</strong> 分析師提供了價格目標的洞察，給出對 Fortrea Holdings 股票未來價值的估計。這一比較揭示了分析師預期隨時間變化的趨勢。</li>
</ul>
</div><p>For valuable insights into Fortrea Holdings's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<div class="lb-trans"><p>為了獲取有關 Fortrea Holdings 市場表現的有價值洞察，請考慮將這些分析師評估與關鍵財務指標結合起來。保持信息靈通，利用我們的評級表做出明智的決策。</p>
</div><p>Stay up to date on Fortrea Holdings analyst ratings.</p>
<div class="lb-trans"><p>隨時瞭解 Fortrea Holdings 的分析師評級。</p>
</div><p>If you are interested in following small-cap stock news and performance you can start by tracking it here.</p>
<div class="lb-trans"><p>如果您對跟蹤小型股新聞和表現感興趣，您可以從這裏開始跟蹤。</p>
</div><h2>About Fortrea Holdings</h2>
<div class="lb-trans"><h2>關於 Fortrea Holdings</h2>
</div><p>Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.</p>
<div class="lb-trans"><p>Fortrea 是一家全球性的晚期合同研究組織，提供從第一階段到第四階段的臨牀試驗管理、臨牀藥理學和患者接入解決方案。該公司與新興和大型生物製藥、醫療設備和診斷公司合作，作為功能服務提供商、全方位服務提供商進行臨牀試驗，並提供混合試驗。2023 年，Fortrea 作為一家獨立的上市公司成立，此前 Labcorp 將其臨牀開發業務剝離，該業務是通過 2015 年以 61 億美元收購 Covance 而獲得的。Fortrea 在 90 個國家擁有 19,000 名員工。</p>
</div><h3>Fortrea Holdings: Delving into Financials</h3>
<div class="lb-trans"><h3>Fortrea Holdings：深入財務分析</h3>
</div><p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<div class="lb-trans"><p><strong>市值視角：</strong> 該公司的市值低於行業平均水平，表明其相較於同行規模相對較小。這一定位可能受到感知增長潛力或運營規模等因素的影響。</p>
</div><p><strong>Revenue Growth:</strong> Fortrea Holdings's revenue growth over a period of 3M has been noteworthy. As of 30 September, 2025, the company achieved a revenue growth rate of approximately <strong>3.91%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<div class="lb-trans"><p><strong>收入增長：</strong> Fortrea Holdings 在過去 3 個月的收入增長顯著。截至 2025 年 9 月 30 日，該公司的收入增長率約為 <strong>3.91%</strong>。這表明公司的頂線收益有了顯著增加。與競爭對手相比，該公司面臨困難，增長率低於醫療保健行業同行的平均水平。</p>
</div><p><strong>Net Margin:</strong> Fortrea Holdings's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-2.27%,</strong> the company may face hurdles in effective cost management.</p>
<div class="lb-trans"><p><strong>淨利潤率：</strong> Fortrea Holdings 的淨利潤率低於行業平均水平，表明在保持強勁盈利能力方面可能面臨挑戰。淨利潤率為 <strong>-2.27%</strong>，公司在有效成本管理方面可能面臨困難。</p>
</div><p><strong>Return on Equity (ROE):</strong> Fortrea Holdings's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-2.72%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<div class="lb-trans"><p><strong>股本回報率（ROE）：</strong> Fortrea Holdings 的 ROE 低於行業標準，表明在有效利用股本方面存在困難。ROE 為 <strong>-2.72%</strong>，公司可能面臨為股東提供滿意回報的挑戰。</p>
</div><p><strong>Return on Assets (ROA):</strong> Fortrea Holdings's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>-0.57%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<div class="lb-trans"><p><strong>資產回報率（ROA）：</strong> Fortrea Holdings 的 ROA 低於行業平均水平，表明在有效利用資產方面存在挑戰。ROA 為 <strong>-0.57%</strong>，公司可能面臨從其資產中產生最佳回報的困難。</p>
</div><p><strong>Debt Management:</strong> Fortrea Holdings's debt-to-equity ratio surpasses industry norms, standing at <strong>2.04</strong>. This suggests the company carries a substantial amount of debt, posing potential financial challenges.</p>
<div class="lb-trans"><p><strong>債務管理：</strong> Fortrea Holdings 的債務與股本比率超過行業規範，達到 <strong>2.04</strong>。這表明公司承擔了大量債務，可能面臨財務挑戰。</p>
</div><h2>What Are Analyst Ratings?</h2>
<div class="lb-trans"><h2>什麼是分析師評級？</h2>
</div><p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<div class="lb-trans"><p>評級來自分析師或銀行和金融系統內的專家，他們針對特定股票或定義的行業進行報告（通常每季度對每隻股票進行一次）。分析師通常從公司電話會議和會議、財務報表以及與重要內部人士的對話中獲取信息，以做出決策。</p>
</div><p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<div class="lb-trans"><p>除了標準評估外，一些分析師還會對增長預估、收益和收入等指標提供預測，為投資者提供額外的指導。使用分析師評級的用户應注意，這些專業建議受到人類觀點的影響，可能會存在變動。</p>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並經過編輯審核。</p>
</div>

專家展望：從 6 位分析師的視角看 Fortrea Holdings